Cardiomyopathy Trial, Recruiting (NCT07009639)

Cardiomyopathy Trial, Recruiting NCT07009639 Sponsor: University of Calabria Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT07009639 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 85 years of age
People who are currently admitted to a Cardiac Care Unit (a specialised hospital ward for serious heart conditions) due to an acute heart problem, such as a heart attack, heart failure, or dangerous irregular heartbeats
People who are able to give written consent to take part in the study

Who may not be able to join:

People whose condition is so unstable that performing an ultrasound scan of the heart (called an echocardiogram) would not be safe or appropriate
People for whom a heart ultrasound scan cannot produce a clear enough image to properly assess the heart's structure and function
People who are unable to continue in the study, whether due to their medical condition, practical/logistical reasons, or personal choice to withdraw

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390984681877

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07009639

Sponsor: University of Calabria

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +390984681877

More information: https://clinicaltrials.gov/study/NCT07009639

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 85 years of age
People who are currently admitted to a Cardiac Care Unit (a specialised hospital ward for serious heart conditions) due to an acute heart problem, such as a heart attack, heart failure, or dangerous irregular heartbeats
People who are able to give written consent to take part in the study

Who may not be able to join:

People whose condition is so unstable that performing an ultrasound scan of the heart (called an echocardiogram) would not be safe or appropriate
People for whom a heart ultrasound scan cannot produce a clear enough image to properly assess the heart's structure and function
People who are unable to continue in the study, whether due to their medical condition, practical/logistical reasons, or personal choice to withdraw

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Calabria

Registry

ClinicalTrials.gov

Start date

1 July 2025

Est. completion

1 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Echocardiographic acquisition times changes; Change in left atrial reservoir strain (LASr) between admission and discharge; Change in left atrial conduit strain (LAScd) between admission and discharge; Change in left atrial contractile strain (LASct) between admission and discharge Description; Correlation between atrial strain variation (ΔLASr, ΔLASct, ΔLAScd) and in-hospital heart failure worsening

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov